To demonstrate the efficacy and safety of a cost-effective and convenient treatment regimen for the delivery of aerosol tobramycin to patients with CF who are chronically colonized with P. aeruginosa, and who have evidence of moderate-severe obstructive airway disease. Specifically, this project will attempt to answer the following question: Is the administration of tobramycin by inhalation twice daily for 28 days efficacious and safe in patients with CF who are chronically colonized with P. aeruginosa?
Showing the most recent 10 out of 563 publications